Esperion Therapeutics, Inc. (ESPR)
3.35
-0.01
(-0.30%)
USD |
NASDAQ |
Feb 27, 16:00
3.35
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Research and Development Expense (TTM) : 44.90M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 116.36M |
| Rigel Pharmaceuticals, Inc. | 28.24M |
| Harrow, Inc. | 13.97M |
| AnaptysBio, Inc. | 152.43M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |